84O Neoadjuvant nivolumab (N) + platinum-doublet chemotherapy (C) for resectable NSCLC: 3-y update from CheckMate 816

P.M. Forde, J. Spicer, N. Girard, M. Provencio, S. Lu, C. Wang, M. Awad, T. Mitsudomi, E. Felip, S.J. Swanson, G. Saylors, K-N. Chen, F. Tanaka, P. Tran, N. Hu, Jingsheng Cai, Judith Bushong, J. Neely, D. Balli, S.R. Broderick